NMRA: Neumora Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Neumora Therapeutics Inc (NMRA).
$1.71B Market Cap.
NMRA Market Cap. (MRY)
NMRA Shares Outstanding (MRY)
NMRA Assets (MRY)
Total Assets
$316.97M
Total Liabilities
$29.91M
Total Investments
$165.43M
NMRA Income (MRY)
Revenue
$0
Net Income
-$243.79M
Operating Expense
$263.46M
NMRA Cash Flow (MRY)
CF Operations
-$182.94M
CF Investing
-$70.56M
CF Financing
$21.60M
NMRA Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $316,972,000 (-36.12%) | $496,195,000 (16.41%) | $426,234,000 (-0.71%) | $429,297,000 |
Assets Current | $314,055,000 (-34.34%) | $478,279,000 (23.28%) | $387,955,000 (-6.65%) | $415,603,000 |
Assets Non-Current | $2,917,000 (-83.72%) | $17,916,000 (-53.20%) | $38,279,000 (179.53%) | $13,694,000 |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Shareholders Equity | $287,064,000 (-38.80%) | $469,076,000 (204.97%) | -$446,850,000 (-37.40%) | -$325,221,000 |
Property Plant & Equipment Net | $2,917,000 (-57.47%) | $6,858,000 (-35.56%) | $10,642,000 (163.35%) | $4,041,000 |
Cash & Equivalents | $143,361,000 (-61.80%) | $375,251,000 (54.93%) | $242,206,000 (-40.83%) | $409,372,000 |
Accumulated Other Comprehensive Income | $62,000 (181.58%) | -$76,000 (90.18%) | -$774,000 (0%) | $0 |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Total Investments | $165,430,000 (84.24%) | $89,789,000 (-41.87%) | $154,452,000 (0%) | $0 |
Investments Current | $165,430,000 (106.93%) | $79,944,000 (-38.95%) | $130,941,000 (0%) | $0 |
Investments Non-Current | $0 (0%) | $9,845,000 (-58.13%) | $23,511,000 (0%) | $0 |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Trade & Non-Trade Payables | $3,307,000 (881.31%) | $337,000 (-95.28%) | $7,147,000 (336.06%) | $1,639,000 |
Accumulated Retained Earnings (Deficit) | -$947,221,000 (-34.66%) | -$703,434,000 (-50.46%) | -$467,509,000 (-38.89%) | -$336,605,000 |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Total Debt | $1,853,000 (-64.58%) | $5,231,000 (-38.04%) | $8,442,000 (311.40%) | $2,052,000 |
Debt Current | $1,853,000 (-45.15%) | $3,378,000 (0.24%) | $3,370,000 (219.13%) | $1,056,000 |
Debt Non-Current | $0 (0%) | $1,853,000 (-63.47%) | $5,072,000 (409.24%) | $996,000 |
Total Liabilities | $29,908,000 (10.28%) | $27,119,000 (-7.75%) | $29,397,000 (19.21%) | $24,660,000 |
Liabilities Current | $29,886,000 (19.02%) | $25,111,000 (5.97%) | $23,697,000 (1.80%) | $23,278,000 |
Liabilities Non-Current | $22,000 (-98.90%) | $2,008,000 (-64.77%) | $5,700,000 (312.45%) | $1,382,000 |
NMRA Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Selling General & Administrative Expense | $62,537,000 (37.52%) | $45,475,000 (46.12%) | $31,121,000 (26.78%) | $24,547,000 |
Research & Development Expense | $200,927,000 (40.79%) | $142,719,000 (55.55%) | $91,749,000 (64.50%) | $55,776,000 |
Operating Expenses | $263,464,000 (4.51%) | $252,098,000 (85.54%) | $135,870,000 (-42.75%) | $237,323,000 |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Income Tax Expense | $178,000 (-33.58%) | $268,000 (0%) | $0 (0%) | $0 |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Consolidated Income | -$243,787,000 (-3.33%) | -$235,925,000 (-80.23%) | -$130,904,000 (44.84%) | -$237,312,000 |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Net Income | -$243,787,000 (-3.33%) | -$235,925,000 (-80.23%) | -$130,904,000 (44.84%) | -$237,312,000 |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Net Income Common Stock | -$243,787,000 (-3.33%) | -$235,925,000 (-80.23%) | -$130,904,000 (44.84%) | -$237,312,000 |
Weighted Average Shares | $159,377,000 (145.12%) | $65,021,000 (138.99%) | $27,207,000 (-84.16%) | $171,815,000 |
Weighted Average Shares Diluted | $159,377,000 (145.12%) | $65,021,000 (138.99%) | $27,207,000 (-84.16%) | $171,815,000 |
Earning Before Interest & Taxes (EBIT) | -$243,609,000 (-3.37%) | -$235,657,000 (-80.02%) | -$130,904,000 (44.84%) | -$237,312,000 |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Operating Income | -$263,464,000 (-4.51%) | -$252,098,000 (-85.54%) | -$135,870,000 (42.75%) | -$237,323,000 |
NMRA Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$70,557,000 (-209.58%) | $64,387,000 (138.32%) | -$168,013,000 (-20464.63%) | -$817,000 |
Net Cash Flow from Financing | $21,603,000 (-90.69%) | $231,936,000 (100.39%) | $115,743,000 (-60.57%) | $293,507,000 |
Net Cash Flow from Operations | -$182,936,000 (-12.04%) | -$163,278,000 (-42.11%) | -$114,896,000 (-52.34%) | -$75,420,000 |
Net Cash Flow / Change in Cash & Cash Equivalents | -$231,890,000 (-274.29%) | $133,045,000 (179.59%) | -$167,166,000 (-176.94%) | $217,270,000 |
Net Cash Flow - Business Acquisitions and Disposals | -$775,000 (83.12%) | -$4,590,000 (64.69%) | -$13,000,000 (0%) | $0 |
Net Cash Flow - Investment Acquisitions and Disposals | -$69,782,000 (-201.00%) | $69,094,000 (144.72%) | -$154,502,000 (0%) | $0 |
Capital Expenditure | $0 (0%) | -$117,000 (77.10%) | -$511,000 (37.45%) | -$817,000 |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Issuance (Purchase) of Equity Shares | $21,603,000 (-90.84%) | $235,740,000 (5419.55%) | $4,271,000 (23.12%) | $3,469,000 |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Share Based Compensation | $39,990,000 (131.96%) | $17,240,000 (107.76%) | $8,298,000 (94.15%) | $4,274,000 |
Depreciation Amortization & Accretion | $3,921,000 (-2.54%) | $4,023,000 (49.17%) | $2,697,000 (73.89%) | $1,551,000 |
NMRA Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -69.00% (96.75%) | -2123.00% (-6362.54%) | 33.90% | - |
Return on Average Assets (ROAA) | -64.00% (-25.00%) | -51.20% (-67.32%) | -30.60% | - |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | -145.20% (16.89%) | -174.70% (-11.77%) | -156.30% | - |
Dividend Yield | 0% (0%) | 0% | - | - |
Price to Earnings Ratio (P/E) | -6.93 (-47.50%) | -4.7 | - | - |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 5.97 (7.50%) | 5.55 | - | - |
Debt to Equity Ratio (D/E) | 0.1 (79.31%) | 0.06 (187.88%) | -0.07 (13.16%) | -0.08 |
Earnings Per Share (EPS) | -1.53 (57.85%) | -3.63 (24.53%) | -4.81 (-248.55%) | -1.38 |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 |
Free Cash Flow Per Share (FCFPS) | -1.15 (54.32%) | -2.51 (40.76%) | -4.24 (-855.41%) | -0.44 |
Book Value Per Share (BVPS) | 1.8 (-75.03%) | 7.21 (143.92%) | -16.42 (-767.62%) | -1.89 |
Tangible Assets Book Value Per Share (TABVPS) | 1.99 (-73.94%) | 7.63 (-51.29%) | 15.67 (526.89%) | 2.5 |
Enterprise Value Over EBIT (EV/EBIT) | -6 (33.33%) | -9 | - | - |
Enterprise Value Over EBITDA (EV/EBITDA) | -6 (36.70%) | -9.48 | - | - |
Asset Turnover | 0 (0%) | 0 (0%) | 0 | - |
Current Ratio | 10.51 (-44.83%) | 19.05 (16.35%) | 16.37 (-8.31%) | 17.85 |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Free Cash Flow (FCF) | -$182,936,000 (-11.96%) | -$163,395,000 (-41.58%) | -$115,407,000 (-51.38%) | -$76,237,000 |
Enterprise Value (EV) | $1,438,365,278 (-34.51%) | $2,196,237,538 | - | - |
Earnings Before Tax (EBT) | -$243,609,000 (-3.37%) | -$235,657,000 (-80.02%) | -$130,904,000 (44.84%) | -$237,312,000 |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$239,688,000 (-3.48%) | -$231,634,000 (-80.67%) | -$128,207,000 (45.62%) | -$235,761,000 |
Invested Capital | $145,578,000 (44.05%) | $101,064,000 (-40.12%) | $168,773,000 (13072.56%) | -$1,301,000 |
Working Capital | $284,169,000 (-37.29%) | $453,168,000 (24.41%) | $364,258,000 (-7.15%) | $392,325,000 |
Tangible Asset Value | $316,972,000 (-36.12%) | $496,195,000 (16.41%) | $426,234,000 (-0.71%) | $429,297,000 |
Market Capitalization | $1,712,547,278 (-34.22%) | $2,603,591,538 | - | - |
Average Equity | $353,401,000 (3080.07%) | $11,113,000 (102.88%) | -$386,035,500 | - |
Average Assets | $381,048,250 (-17.38%) | $461,214,500 (7.82%) | $427,765,500 | - |
Invested Capital Average | $167,786,250 (24.36%) | $134,918,500 (61.12%) | $83,736,000 | - |
Shares | 161,561,064 (5.80%) | 152,703,316 (11.27%) | 137,239,096 | - |
